ZCCN INFO
832171
WUXI JINGHAI
836547
KLT
831689
4
TIRAIN
430564
5
ZHONGKE MEILING
835892
Allarity Therapeutics, Inc. engages in the development of drugs for personalized treatment of cancer guided by its proprietary Drug Response Predictor (DRP) technology. The company operates in two geographic areas: Denmark and the United States. The company was founded on April 4, 2021 and is headquartered in Boston, MA.